Mr Matthew Gerard Winston Frohn

venture capitalBRITISHUNITED KINGDOMBorn February 1967

Risk Flags

Director of 1 company with insolvency proceedings

Current Appointments
20

Longwall Ventures 4 Ecf (Gp) Llp

llp designated member · Since 18/02/2026

active
active
Longwall Ventures 4 Ecf (Fp) Llp

llp designated member · Since 13/02/2026

active
Momentum Bioscience Limited

director · Since 28/10/2019

Liquidation
Caristo Diagnostics Limited

director · Since 22/06/2018

Active
Longwall Ventures 3 Ecf (Nominee) Limited

director · Since 12/09/2017

active
Longwall Ventures 3 Ecf (Gp) Llp

llp designated member · Since 11/09/2017

active
active
Longwall Ventures 3 Ecf (Fp) Llp

llp designated member · Since 07/09/2017

active
Oxsonics Limited

director · Since 20/11/2013

Active
Oxford Technology Ecf (Gp) Member Limited

director · Since 29/11/2012

active
Longwall Ventures Ecf (Gp) Member Limited

director · Since 09/11/2012

active
Longwall Ventures Ecf (Gp) Llp

llp designated member · Since 08/10/2012

active
Longwall Ventures Ecf (Fp) Llp

llp designated member · Since 08/10/2012

active
Microvisk Ip Limited

director · Since 19/10/2011

Longwall Venture Partners Llp

llp designated member · Since 18/03/2011

active
Crysalin Limited

director · Since 06/07/2010

Base4 Innovation Ltd

director · Since 16/12/2008

Oxford Technology Ecf (Gp) Llp

llp designated member · Since 09/12/2007

active
Oxford Technology Ecf (Fp) Llp

llp designated member · Since 09/12/2007

active

Insolvency Proceedings

Momentum Bioscience Limited

creditors voluntary liquidation

creditors

Summary

Current roles20
Former roles0
Occupationventure capital
NationalityBRITISH
Based inUNITED KINGDOM
DOBBorn February 1967
Risk flags Medium risk

Financial FootprintActive cos.

Combined net worth£5.1m
Total employees46

Based on latest filed accounts for 3 of 20 active companies.

Data sourced from Companies House public register. Financial data from filed accounts. Updated as filings are processed.